Inactive Instrument

News Bovie Medical Corporation Nyse

Equities

US10211F1003

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

APYX MEDICAL CORPORATION SHOWCASES NEW DATA AND TREATMENT INSIGHTS AT THE RENUVION USERS' SUMMIT	Apr. 12	AQ
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit	Apr. 11	BU
APYX MEDICAL CORPORATION REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS, INTRODUCES FULL YEAR 2024 FINANCIAL OUTLOOK	Mar. 22	AQ
Transcript : Apyx Medical Corporation, Q4 2023 Earnings Call, Mar 21, 2024	Mar. 21
Apyx: Q4 Earnings Snapshot	Mar. 21	AQ
Apyx Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook	Mar. 21	BU
Apyx Medical Corporation Provides Earnings Guidance for the Year Ending December 31, 2024	Mar. 21	CI
Apyx Medical Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 21	CI
North American Morning Briefing : Investors -2-	Mar. 21	DJ
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024	Mar. 04	BU
APYX MEDICAL CORPORATION ANNOUNCES RENUVION TO BE FEATURED IN EDUCATIONAL SESSIONS AT THE AMERICAN ACADEMY OF COSMETIC SURGERY SCIENTIFIC MEETING	Feb. 22	AQ
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting	Feb. 21	BU
APYX MEDICAL CORPORATION ANNOUNCES PEER-REVIEWED CLINICAL PUBLICATION EVALUATING THE SAFETY OF RENUVION FOLLOWING LIPOSUCTION IN MULTIPLE AREAS OF THE BODY	Jan. 23	AQ
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body	Jan. 22	BU
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body	Jan. 22	CI
Apyx Medical Reports Q4, Full-Year 2023 Preliminary Revenue	Jan. 08	MT
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results	Jan. 08	BU
Apyx Medical Corporation Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	Jan. 08	CI
Apyx Medical Names Matthew Hill as CFO	Nov. 28	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bovie Medical Corporation Nyse

Equities

US10211F1003

Summary

Filters